tm logo
LYBALVI
Live/Pending
STATEMENT OF USE - TO EXAMINER

to examiner

on 26 May 2023

Last Applicant/ Owned by

1 Burlington Road

Dublin 4

IE

Serial Number

90765835 filed on 10th Jun 2021

Registration Number

N/A

Correspondent Address

Norm J. Rich

Norm J. Rich

SIXTH FLOOR

3000 K STREET, N.W.

WASHINGTON, DC 20007

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LYBALVI

Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes


First Use Date in General

21st Jan 2022

First Use Date in Commerce

23rd Feb 2022

Class [035]
Advertising, Business & Retail Services


Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms


First Use Date in General

21st Jan 2022

First Use Date in Commerce

23rd Feb 2022

Class [036]
Insurance & Financial Services


Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs


First Use Date in General

21st Jan 2022

First Use Date in Commerce

23rd Feb 2022

Class [045]
Personal & Legal & Social Services


Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program


First Use Date in General

21st Jan 2022

First Use Date in Commerce

23rd Feb 2022

Specimens


LYBALVI specimen

Mark Details


Serial Number

No 90765835

Mark Type

No Service Mark

Attorney Docket Number

No 029318-2842

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th May 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th May 2023SOU EXTENSION 1 GRANTED
26th May 2023STATEMENT OF USE PROCESSING COMPLETE
25th May 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
19th May 2023SOU EXTENSION 1 FILED
19th May 2023TEAS EXTENSION RECEIVED
19th May 2023TEAS STATEMENT OF USE RECEIVED
19th May 2023USE AMENDMENT FILED
29th Nov 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17th Oct 2022NEW NOA TO ISSUE